Indapamid Stada (Indapamide)

Indapamide works by blocking the sodium‑chloride cotransporter in the distal convoluted tubule of the kidney. This inhibition reduces reabsorption of sodium and chloride, leading to increased urinary loss of these ions along with water. The resulting decrease in plasma volume and peripheral vascular resistance lowers blood pressure and reduces edema.

The appropriate dose of Indapamid Stada is determined by the prescribing healthcare professional based on the individual’s medical condition, response to therapy, and renal function. Dosage adjustments are made according to clinical guidelines and patient-specific factors; patients should follow the prescriber’s instructions exactly.

Safety of indapamide during pregnancy or lactation has not been definitively established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant. Healthcare providers will evaluate the risk‑benefit profile before prescribing it to pregnant or nursing women.

To request Indapamid Stada, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Indapamide belongs to the thiazide‑like diuretic class and offers a longer duration of action with a lower incidence of metabolic disturbances compared with classic thiazides such as hydrochlorothiazide. It is often preferred when sustained blood‑pressure control and modest diuretic effect are needed, while still being effective for edema management.

Indapamid Stada should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging to protect it from moisture and light, and store it out of reach of children.

Indapamid Stada is taken orally, usually with a glass of water. The tablet should be swallowed whole and can be taken with or without food, unless the prescriber advises otherwise. Patients should follow the dosing schedule provided by their healthcare professional.

Serious risks include severe dehydration, significant electrolyte imbalances such as hyponatremia or hypokalemia, allergic reactions, and profound hypotension. Patients should be monitored for signs of these conditions, especially during the initial weeks of therapy or when combined with other medications that affect fluid and electrolyte balance.

Indapamid Stada is contraindicated in patients with known hypersensitivity to indapamide or other sulfonamide-derived drugs, in those with severe renal impairment, and in individuals with anuria. Caution is also advised for patients with severe liver disease, uncontrolled diabetes, or those taking medications that may cause dangerous electrolyte disturbances.